FemtoDx
FemtoDx is dedicated to revolutionizing at-home monitoring of chronic and acute diseases through innovative silicon sensor chip technology. Their solutions enable lab-quality, quantitative tests for various health conditions, providing instant results and cloud connectivity for clinical decision-making. The company focuses on non-invasive diagnostics, drug safety monitoring, and early detection of diseases like MASH and heart failure, aiming to improve patient care and prevent hospitalizations.
Industries
Nr. of Employees
small (1-50)
FemtoDx
Beverly Hills, California, United States, North America
Products
At-home biomarker reader and single-use cartridge platform
A point-of-care system concept consisting of a reusable reader and marker-specific single-use cartridges designed for at-home or clinic use to deliver quantitative biomarker results in 2–10 minutes and transmit data to clinicians via cloud/EHR connectivity.
At-home biomarker reader and single-use cartridge platform
A point-of-care system concept consisting of a reusable reader and marker-specific single-use cartridges designed for at-home or clinic use to deliver quantitative biomarker results in 2–10 minutes and transmit data to clinicians via cloud/EHR connectivity.
Services
Partnerships for regulatory and clinical development
Collaborative service to support drug safety monitoring requirements, regulatory approval strategies, lifecycle management, and integration of diagnostic device capabilities into clinical trials and post-market monitoring.
Point-of-care and at-home platform development and integration
Development and integration of reader, single-use cartridges, assay workflows, and cloud/EHR connectivity for point-of-care and at-home biomarker testing.
Partnerships for regulatory and clinical development
Collaborative service to support drug safety monitoring requirements, regulatory approval strategies, lifecycle management, and integration of diagnostic device capabilities into clinical trials and post-market monitoring.
Point-of-care and at-home platform development and integration
Development and integration of reader, single-use cartridges, assay workflows, and cloud/EHR connectivity for point-of-care and at-home biomarker testing.
Expertise Areas
- Point-of-care and at-home diagnostic development
- Biosensor platform engineering
- Assay development for antibody/aptamer/enzyme/nucleic acid formats
- Multiplexed low-volume biomarker quantification
Key Technologies
- Silicon sensor chips
- Label-free electrical detection
- Nanowire field-effect transistor biosensors
- Multiplexed micro-sensor arrays